Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection
- PMID: 28187279
- DOI: 10.1016/j.cell.2017.01.030
Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection
Abstract
Curative therapies are most successful when cancer is diagnosed and treated at an early stage. We advocate that technological advances in next-generation sequencing of circulating, tumor-derived nucleic acids hold promise for addressing the challenge of developing safe and effective cancer screening tests.
Copyright © 2017. Published by Elsevier Inc.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
